Dutch State to sell share capital of Intravacc BV

Two years after the establishment of the private company Intravacc BV (Bilthoven, The Netherlands), the sale of the former Netherlands Vaccine...

Phialogics AG bags pre-seed financing

Basel-based Phialogics AG, which was spun-off from Fraunhofer Institute for Immune Pathology and Immune Tolerance in 2021, has cashed in a pre-seed...

LSP Dementia Fund closes at €260m

Investors included the Alzheimer’s Association, the European Investment Fund EIF, several unnamed global pharmaceutical, and insurance companies,...

Nomi Biotech presents natural additive to preserve probiotics

Nomi Biotech sp zoo has presented a water-soluble formulation of curcumin with improved bioavailability in Frontiers in Nutrition allowing to...

Novartis in US$465m deal with 3B Pharmaceuticals GmbH

Under the agreement, which foresees US$425m in milestones plus royalities on future sales for 3B Pharmaceuticals GmbH (3BP), Basel-based pharma...

Algal enzyme synthesizes gasoline building blocks

Deciphering the mechanism of the photoenzyme Fatty acid photodecarboxylase (FAP), a research team co-headed by Frederic Beisson from University...

Ariceum Therapeutics extends Series A to €47.75m

The Series A financing was co-led by new investors Andera Partners and Earlybird Venture Capital. Existing investor Pureos Bioventures doubled its...